South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs
![](https://article-imgs.scribdassets.com/97l8mrsby8bp3lsy/images/fileAUQAJCTR.jpg)
South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.
Experts see it as a shift in how such countries deal with pharmaceutical behemoths and say it could trigger more efforts to make lifesaving medicines more widely available.
In the COVID-19 pandemic, rich countries bought most of the world’s vaccines early, leaving few shots for poor countries and creating a disparity the World Health Organization called “a catastrophic moral failure.”
Now, poorer countries are trying to become more self-reliant “because they’ve realized after COVID
You’re reading a preview, subscribe to read more.
Start your free 30 days